Log In
BCIQ
Print this Print this
 

iSPERSE salmeterol/fluticasone

  Manage Alerts
Collapse Summary General Information
Company Pulmatrix Inc.
DescriptionInhaled dry powder formulation of salmeterol and fluticasone using the iSPERSE drug delivery platform
Molecular Target Adrenergic receptor beta 2 (ADRB2) ; Corticoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/16/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today